Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AvePoint (AVPT) Cash & Equivalents (2019 - 2026)

AvePoint (AVPT) has 8 years of Cash & Equivalents data on record, last reported at $444.1 million in Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 26.36% to $444.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $444.1 million, a 26.36% increase, with the full-year FY2025 number at $481.1 million, up 65.46% from a year prior.
  • Cash & Equivalents reached $444.1 million in Q1 2026 per AVPT's latest filing, down from $481.1 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for AVPT hit a ceiling of $481.1 million in Q4 2025 and a floor of $65.1 million in Q2 2022.
  • A 5-year average of $272.2 million and a median of $227.2 million in 2022 define the central range for Cash & Equivalents.
  • On a YoY basis, Cash & Equivalents climbed as much as 56364.89% in 2022 and fell as far as 16.46% in 2022.
  • Tracing AVPT's Cash & Equivalents over 5 years: stood at $227.2 million in 2022, then fell by 1.77% to $223.2 million in 2023, then skyrocketed by 30.28% to $290.7 million in 2024, then soared by 65.46% to $481.1 million in 2025, then decreased by 7.68% to $444.1 million in 2026.
  • Business Quant data shows Cash & Equivalents for AVPT at $444.1 million in Q1 2026, $481.1 million in Q4 2025, and $471.6 million in Q3 2025.